Pettinga Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Pettinga Financial Advisors, LLC

  • $416 Million
  • Q3 2024

A detailed history of Pettinga Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pettinga Financial Advisors, LLC holds 11,108 shares of BMY stock, worth $598,721. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,108
Previous 11,108 -0.0%
Holding current value
$598,721
Previous $574,000 -0.0%
% of portfolio
0.14%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$39.66 - $51.75 $35,138 - $45,850
886 Added 8.67%
11,108 $574,000
Q2 2024

Jul 25, 2024
SELL
$40.25 - $52.99 $11,712 - $15,420
-291 Reduced 2.77%
10,222 $424,000
Q1 2024

Apr 17, 2024
BUY
$47.98 - $54.4 $9,596 - $10,880
200 Added 1.94%
10,513 $570,000
Q4 2023

Jan 18, 2024
BUY
$48.48 - $57.85 $969 - $1,157
20 Added 0.19%
10,313 $529,000
Q2 2023

Jul 17, 2023
SELL
$63.71 - $70.74 $6,371 - $7,073
-100 Reduced 0.96%
10,293 $658,000
Q1 2023

Apr 20, 2023
BUY
$65.71 - $74.53 $1,971 - $2,235
30 Added 0.29%
10,393 $720,000
Q4 2022

Jan 12, 2023
SELL
$68.48 - $81.09 $8,628 - $10,217
-126 Reduced 1.2%
10,363 $0
Q2 2022

Jul 19, 2022
SELL
$72.62 - $79.98 $10,893 - $11,997
-150 Reduced 1.41%
10,489 $808,000
Q1 2022

Apr 27, 2022
SELL
$61.48 - $73.72 $81,461 - $97,679
-1,325 Reduced 11.07%
10,639 $777,000
Q4 2021

Feb 09, 2022
BUY
$53.63 - $62.52 $27,887 - $32,510
520 Added 4.54%
11,964 $746,000
Q3 2021

Oct 29, 2021
BUY
$59.17 - $69.31 $11,123 - $13,030
188 Added 1.67%
11,444 $677,000
Q2 2021

Aug 12, 2021
SELL
$61.91 - $67.42 $6,376 - $6,944
-103 Reduced 0.91%
11,256 $752,000
Q1 2021

Apr 29, 2021
SELL
$59.34 - $66.74 $7,239 - $8,142
-122 Reduced 1.06%
11,359 $717,000
Q4 2020

Jan 29, 2021
SELL
$57.74 - $65.43 $6,755 - $7,655
-117 Reduced 1.01%
11,481 $712,000
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $28,715 - $31,820
-500 Reduced 4.13%
11,598 $699,000
Q2 2020

Jul 22, 2020
SELL
$54.82 - $64.09 $3,672 - $4,294
-67 Reduced 0.55%
12,098 $711,000
Q1 2020

May 11, 2020
SELL
$46.4 - $67.43 $17,353 - $25,218
-374 Reduced 2.98%
12,165 $678,000
Q4 2019

Feb 07, 2020
SELL
$49.21 - $64.19 $11,170 - $14,571
-227 Reduced 1.78%
12,539 $805,000
Q3 2019

Oct 17, 2019
SELL
$42.77 - $50.71 $2,138 - $2,535
-50 Reduced 0.39%
12,766 $647,000
Q2 2019

Jul 31, 2019
BUY
$44.62 - $49.34 $142,070 - $157,098
3,184 Added 33.06%
12,816 $581,000
Q4 2018

Feb 01, 2019
BUY
$48.76 - $63.23 $469,656 - $609,031
9,632 New
9,632 $501,000

Others Institutions Holding BMY

# of Institutions
2,729
Shares Held
1.57B
Call Options Held
30M
Put Options Held
31.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pettinga Financial Advisors, LLC Portfolio

Follow Pettinga Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email